Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

pembrolizumab 257 Cyclophosphamide 241 Specimen Handling 198 fludarabine 173 Magnetic Resonance Spectroscopy 173 Biopsy 147 Nivolumab 119 Carboplatin 97 Radiotherapy 92 Paclitaxel 85 venetoclax 82 Cisplatin 80 Gemcitabine 79 fludarabine phosphate 78 Injections 68 Ipilimumab 64 Dexamethasone 61 atezolizumab 59 Bevacizumab 58 Cetuximab 57 Radiation 55 Fluorouracil 55 Azacitidine 55 durvalumab 54 Radiosurgery 52 Temozolomide 47 Rituximab 44 Oxaliplatin 44 Irinotecan 43 Docetaxel 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NIS-793 × 1 year × Clear all

NCT05417386 2025-11-18

FOLFIRINOX + NIS793 in Pancreatic Cancer

Massachusetts General Hospital

Phase 1 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡